Barberich; Timothy J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barberich; Timothy J..The latest application filed is for "(r,r) formoterol in combination with other pharmacological agents".

Company Profile

0.23.26

Barberich; Timothy J. - Concord MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(r,r) Formoterol In Combination With Other Pharmacological Agents App 20150209311 - Barberich; Timothy J.	2015-07-30
Dopamine-agonist combination therapy for improving sleep quality Grant 8,877,755 - Barberich November 4, 2	2014-11-04
Combination Of A Sedative And A Neurotransmitter Modulator, And Methods For Treating Depression App 20120122874 - LALJI; Karim ; et al.	2012-05-17
Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression Grant 8,097,625 - Lalji , et al. January 17, 2	2012-01-17
Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites Grant 7,714,023 - Barberich May 11, 2	2010-05-11
Dopamine-Agonist Combination Therapy For Improving Sleep Quality App 20100004251 - Barberich; Timothy J.	2010-01-07
(R,r)-Formoterol in Combination with Other Pharmacological Agents App 20080125461 - Barberich; Timothy J.	2008-05-29
Combination Of Sedative And A Neurotransmitter Modulator, And Methods For Improving Sleep Quality And Treating Depression App 20070299055 - Lalji; Karim ; et al.	2007-12-27
S-lansoprazole compositions and methods App 20060142346 - Barberich; Timothy J. ; et al.	2006-06-29
Methods for treating irritable bowel syndrome using optically pure (-) norcisapride Grant 7,064,138 - Rubin , et al. June 20, 2	2006-06-20
Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites Grant 7,030,142 - Barberich , et al. April 18, 2	2006-04-18
Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites App 20060019970 - Barberich; Timothy J. ; et al.	2006-01-26
Dopamine-agonist combination therapy for improving sleep quality App 20050267176 - Barberich, Timothy J.	2005-12-01
Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine App 20050228052 - Barberich, Timothy J.	2005-10-13
Modafinil combination therapy for improving sleep quality App 20050215521 - Lalji, Karim ; et al.	2005-09-29
Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites App 20050192344 - Barberich, Timothy J.	2005-09-01
Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression App 20050176680 - Lalji, Karim ; et al.	2005-08-11
Melatonin combination therapy for improving sleep quality App 20050164987 - Barberich, Timothy J.	2005-07-28
Method for treating and preventing disorders using optically pure (+) norcisapride App 20050154018 - Rubin, Paul D. ; et al.	2005-07-14
Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride Grant 6,835,740 - Rubin , et al. December 28, 2	2004-12-28
S-lansoprazole compositions and methods App 20040224989 - Barberich, Timothy J. ; et al.	2004-11-11
Compositions for treating apnea and related disorders containing optically pure R(+) ondansetron App 20040058973 - Rubin, Paul D. ; et al.	2004-03-25
Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron Grant 6,649,183 - Rubin , et al. November 18, 2	2003-11-18
Methods for treating apnea, apnea disorders, and other disorders using optically pure (-) norcisapride App 20030158229 - Rubin, Paul D. ; et al.	2003-08-21
Methods for treating bulimia using optically pure (-) norcisapride Grant 6,559,165 - Rubin , et al. May 6, 2	2003-05-06
Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists Grant 6,552,045 - Rubin , et al. April 22, 2	2003-04-22
Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists Grant 6,548,518 - Rubin , et al. April 15, 2	2003-04-15
R-lansoprazole compositions and methods App 20030008903 - Barberich, Timothy J. ; et al.	2003-01-09
Compositions and methods employing R (-) fluoxetine and other active ingredients App 20020151543 - Barberich, Timothy J. ; et al.	2002-10-17
Methods for treating apnea and apnea disorders using optically pure (+) norcisapride App 20020147220 - Rubin, Paul D. ; et al.	2002-10-10
Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists App 20020086881 - Rubin, Paul D. ; et al.	2002-07-04
Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists App 20020086880 - Rubin, Paul D. ; et al.	2002-07-04
Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron App 20020051815 - Rubin, Paul D. ; et al.	2002-05-02
R-hydroxynefazodone App 20020052382 - Barberich, Timothy J. ; et al.	2002-05-02
R-lansoprazole compositions and methods App 20020042433 - Yelle, William E. ; et al.	2002-04-11
Methods for treating irritable bowel syndrome using optically pure (+) norcisapride Grant 6,369,079 - Rubin , et al. April 9, 2	2002-04-09
Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists Grant 6,362,202 - Rubin , et al. March 26, 2	2002-03-26
S-lansoprazole compositions and methods App 20010025107 - Barberich, Timothy J. ; et al.	2001-09-27
Method for treating bronchospasm using optically pure R(-) albuterol Grant 6,083,993 - Barberich , et al. July 4, 2	2000-07-04
Method for inducing bronchodilation using optically pure R(-) albuterol Grant 5,844,002 - Barberich , et al. December 1, 1	1998-12-01
Method for treating asthma using optically pure R(-) albuterol Grant 5,760,090 - Barberich , et al. June 2, 1	1998-06-02
Methods of use and compositions of R(-) fluoxetine Grant 5,708,035 - Young , et al. January 13, 1	1998-01-13
Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor Grant 5,648,396 - Young , et al. July 15, 1	1997-07-15
Method for treating migraine headaches using optically pure S(+) fluoxetine Grant 5,589,511 - Young , et al. December 31, 1	1996-12-31
Method for treating asthma using optically pure R(-) albuterol Grant 5,547,994 - Barberich , et al. August 20, 1	1996-08-20
Antipyretic and analgesic methods using optically pure R-ketorolac Grant 5,382,591 - Barberich , et al. January 17, 1	1995-01-17
Method for treating asthma using optically pure (R)-albuterol Grant 5,362,755 - Barberich , et al. November 8, 1	1994-11-08
Methods and compositions for treating depression using optically pure fluoxetine Grant 5,104,899 - Young , et al. April 14, 1	1992-04-14

Company Registrations

SEC

0001120355

BARBERICH TIMOTHY J of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.